Molecular Mechanisms of Targeted Treatments for Solid Tumours

Over the course the morning, Elaine guides you through the scientific concepts that underpin many of the most used targeted cancer treatments for solid tumours.

Elaine begins by describing what we can and can’t target, and the mechanisms of action of monoclonal antibodies and small molecules that block kinases. She then looks at the many treatments that block growth factor controlled signalling pathways. Finally, she turns her attention to other targets and to various biomarker tests to select the right approach for each patient.

This morning is the first part of a virtual study day. On Friday 04 December it is followed by “Molecular Mechanisms of Immunotherapies for Solid Tumours”.

Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
To book, contact:
View the day’s programme